Bianca Rocca
Bianca Rocca
Associate Professor of Pharmacology, Catholic University School of Medicine, Rome
Verified email at
TitleCited byYear
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ...
Science 296 (5567), 539-541, 2002
Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years
GIS Policitemia
Annals of Internal Medicine 123, 656-664, 1995
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
B Rocca, P Secchiero, G Ciabattoni, FO Ranelletti, L Catani, L Guidotti, ...
Proceedings of the National Academy of Sciences 99 (11), 7634-7639, 2002
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a singleá…
M Seri, A Pecci, F Di Bari, R Cusano, M Savino, E Panza, A Nigro, P Noris, ...
Medicine 82 (3), 203-215, 2003
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of theá…
V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ...
European heart journal 39 (34), 3165-3241, 2018
Cyclooxygenases and prostaglandins: shaping up the immune response
B Rocca, GA FitzGerald
International immunopharmacology 2 (5), 603-630, 2002
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin “Resistance”
F Santilli, B Rocca, R De Cristofaro, S Lattanzio, L Pietrangelo, A Habib, ...
Journal of the American College of Cardiology 53 (8), 667-677, 2009
Cardiovascular Responses to the Isoprostanes iPF-III and iPE2-III Are Mediated via the Thromboxane A2 Receptor In Vivo
LP Audoly, B Rocca, JE Fabre, BH Koller, D Thomas, AL Loeb, ...
Circulation 101 (24), 2833-2840, 2000
Cyclooxygenase-2 expression and inhibition in atherothrombosis
F Cipollone, B Rocca, C Patrono
Arteriosclerosis, thrombosis, and vascular biology 24 (2), 246-255, 2004
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes
B Rocca, F Santilli, D Pitocco, L Mucci, G Petrucci, E Vitacolonna, ...
Journal of Thrombosis and Haemostasis 10 (7), 1220-1230, 2012
Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease
A Pecci, E Panza, N Pujol‐Moix, C Klersy, F Di Bari, V Bozzi, P Gresele, ...
Human mutation 29 (3), 409-417, 2008
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development
B Rocca, LM Spain, E PurÚ, R Langenbach, C Patrono, GA FitzGerald
Journal of Clinical Investigation 103 (10), 1469-1477, 1999
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
S Pascale, G Petrucci, A Dragani, A Habib, F Zaccardi, F Pagliaccia, ...
Blood, The Journal of the American Society of Hematology 119 (15), 3595-3603, 2012
Aspirin: promise and resistance in the new millennium
C Patrono, B Rocca
Arteriosclerosis, thrombosis, and vascular biology 28 (3), s25-s32, 2008
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...
European heart journal, 2019
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
F Andreotti, B Rocca, S Husted, RA Ajjan, J ten Berg, M Cattaneo, ...
European Heart Journal 36 (46), 3238-3249, 2015
Drug insight: aspirin resistance—fact or fashion?
C Patrono, B Rocca
Nature clinical practice Cardiovascular medicine 4 (1), 42-50, 2007
Determinants of the interindividual variability in response to antiplatelet drugs
B Rocca, C Patrono
Journal of Thrombosis and Haemostasis 3 (8), 1597-1602, 2005
Prognostic significance of cyclooxygenase‐2 in laryngeal squamous cell carcinoma
FO Ranelletti, G Almadori, B Rocca, G Ferrandina, G Ciabattoni, A Habib, ...
International journal of cancer 95 (6), 343-349, 2001
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment
R Landolfi, B Rocca, C Patrono
Critical reviews in oncology/hematology 20 (3), 203-222, 1995
The system can't perform the operation now. Try again later.
Articles 1–20